Charles River Laboratories CRL Defined Benefit Plan, Actuarial Gain (Loss), Change in Mortality Assumptions
Defined Benefit Plan, Actuarial Gain (Loss), Change in Mortality Assumptions at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:DefinedBenefitPlanActuarialGainLossChangeinMortalityAssumptions.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's defined benefit plan, actuarial gain (loss), change in mortality assumptions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's defined benefit plan, actuarial gain (loss), change in mortality assumptions?
- Charles River Laboratories (CRL) reported defined benefit plan, actuarial gain (loss), change in mortality assumptions of -$875K in Q4 2023.
- What does defined benefit plan, actuarial gain (loss), change in mortality assumptions mean?
- The change in pension liability resulting from updated life expectancy projections for plan participants.
- How do you interpret defined benefit plan, actuarial gain (loss), change in mortality assumptions?
- An increase in life expectancy projections typically leads to an actuarial loss, increasing the pension liability.
- How does defined benefit plan, actuarial gain (loss), change in mortality assumptions compare across companies?
- Standard actuarial adjustment reported by companies with long-term pension commitments.